Definium Therapeutics, Inc. Working Capital to Net Assets Ratio
Definium Therapeutics, Inc. working capital to net assets ratio. Definium Therapeutics, Inc. (DFTX) has a Working Capital to Net Assets ratio of 101.8% as of June 2026. Working capital of $934.90 Million (current assets of $1.09 Billion minus current liabilities of $157.20 Million) is measured against net assets of $918.68 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Definium Therapeutics, Inc. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Definium Therapeutics, Inc. (2015–2025)
Working capital to net assets ratio of Definium Therapeutics, Inc. from 2015 to 2025. This chart shows how Definium Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 101.8%, reflecting working capital of $934.90 Million against net assets of $918.68 Million USD. See defensive interval ratio of Definium Therapeutics, Inc. to measure how many days the company can operate on defensive assets alone.
Definium Therapeutics, Inc. Working Capital to Net Assets Ratio by Year (2015–2025)
Definium Therapeutics, Inc. working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Definium Therapeutics, Inc. from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Definium Therapeutics, Inc. (DFTX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 106.1% | $352.62 Million | $332.33 Million | $419.32 Million | $66.70 Million | ▲ +5.6 pp |
| 2024 | 100.5% | $242.77 Million | $241.45 Million | $281.62 Million | $38.85 Million | ▲ +8.9 pp |
| 2023 | 91.7% | $71.63 Million | $78.13 Million | $103.87 Million | $32.25 Million | ▲ +6.7 pp |
| 2022 | 84.9% | $128.16 Million | $150.92 Million | $146.06 Million | $17.89 Million | ▲ +1.3 pp |
| 2021 | 83.6% | $126.81 Million | $151.66 Million | $137.22 Million | $10.41 Million | ▼ -19.9 pp |
| 2020 | 103.5% | $78.51 Million | $75.87 Million | $81.52 Million | $3.01 Million | ▲ +3.5 pp |
| 2019 | 100.0% | $2.74 Million | $2.74 Million | $2.94 Million | $198.96K | ▲ +94.6 pp |
| 2018 | 5.4% | $190.40K | $3.52 Million | $198.63K | $8.23K | ▼ -37.4 pp |
| 2017 | 42.9% | $1.69 Million | $3.95 Million | $1.77 Million | $80.44K | ▼ -4.9 pp |
| 2016 | 47.7% | $60.72K | $127.28K | $136.19K | $75.47K | ▼ -15.3 pp |
| 2015 | 63.0% | $178.92K | $284.17K | $186.40K | $7.49K | — |